person · Reporting owner

Grossman Fred

Disclosed activity across 1 company

Tapewire entity: 68769
SEC CIK: 0001985154

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Coya Therapeutics, Inc.COYA · Entity 6727	Chief Medical Officer	January 22, 2026	January 26, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Coya Therapeutics, Inc.

Report date January 22, 2026 · Filed January 26, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.73 · Expires 2036-01-22	Direct	140,041	Reported balance After 2026-01-22 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-01-22 · Grant · Acquired 140,041 · Balance 140,041 F1: Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022.

Filing footnotes · ownership attribution and instrument terms

F1: Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
January 22, 2026 Filed Jan 26, 2026 13:00 UTC	Coya Therapeutics, Inc. COYA · Entity 6727	GrantStock Option (right to buy) · Derivative	140,041	$0.00 Strike: $4.73	$0.00	Disclosure SEC source: 0001193125-26-021728 · ownership.xml · derivative · entry 1 Grossman Fred · CIK 0001985154 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,041 Underlying: Common Stock, par value $0.0001 per share · 140,041 shares Expires 2036-01-22 F1 · derivative.exercise_date: Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022. Read SEC document
January 09, 2025 Filed Jan 13, 2025 13:00 UTC	Coya Therapeutics, Inc. COYA · Entity 6727	GrantStock Option (right to buy) · Derivative	140,562	$0.00 Strike: $6.07	$0.00	Disclosure SEC source: 0000950170-25-004572 · ownership.xml · derivative · entry 1 Grossman Fred · CIK 0001985154 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,562 Underlying: Common Stock, par value $0.0001 per share · 140,562 shares Expires 2035-01-09 F1 · derivative.exercise_date: The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date. Read SEC document
November 11, 2024 Filed Nov 12, 2024 23:03 UTC	Coya Therapeutics, Inc. COYA · Entity 6727	PurchaseCommon Stock, par value $0.0001 per share	2,710	$7.37	$19,972.70	Disclosure SEC source: 0001493152-24-044896 · ownership.xml · nonDerivative · entry 1 Grossman Fred · CIK 0001985154 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,710 Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:00 UTC	Coya Therapeutics, Inc. COYA · Entity 6727	GrantStock Option (right to buy) · Derivative	70,596	$0.00 Strike: $8.15	$0.00	Disclosure SEC source: 0000950170-24-069549 · ownership.xml · derivative · entry 1 Grossman Fred · CIK 0001985154 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,596 Underlying: Common Stock · 70,596 shares Expires 2034-06-03 F1 · derivative.exercise_date: Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024. Read SEC document
January 31, 2024 Filed Feb 3, 2024 01:00 UTC	Coya Therapeutics, Inc. COYA · Entity 6727	GrantStock Option (right to buy) · Derivative	74,069	$0.00 Strike: $5.90	$0.00	Disclosure SEC source: 0001493152-24-004813 · ownership.xml · derivative · entry 2 Grossman Fred · CIK 0001985154 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,069 Underlying: Common Stock, par value $0.0001 per share · 74,069 shares Expires 2034-01-31 F2 · derivative.exercise_date: The option will vest as to 24,689 shares on July 11, 2024, with the remaining shares vesting in 24 equal monthly installments. Read SEC document
January 31, 2024 Filed Feb 3, 2024 01:00 UTC	Coya Therapeutics, Inc. COYA · Entity 6727	GrantStock Option (right to buy) · Derivative	81,819	$0.00 Strike: $5.90	$0.00	Disclosure SEC source: 0001493152-24-004813 · ownership.xml · derivative · entry 1 Grossman Fred · CIK 0001985154 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,819 Underlying: Common Stock, par value $0.0001 per share · 81,819 shares Expires 2034-01-31 F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date. Read SEC document
July 17, 2023 Filed Jul 20, 2023 01:05 UTC	Coya Therapeutics, Inc. COYA · Entity 6727	GrantStock Option (right to buy) · Derivative	74,069	Not disclosed Strike: $4.25	Not disclosed	Disclosure SEC source: 0001493152-23-024969 · ownership.xml · derivative · entry 1 Grossman Fred · CIK 0001985154 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,069 Underlying: Common Stock, par value $0.0001 per share · 74,069 shares Expires 2033-07-17 F1 · price: Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024. F1 · derivative.exercise_date: Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.